SCHEMBL18044508

SCHEMBL18044508

CCOC(=O)CC1CCN(C(=O)OC(C)(C)C)CC1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.41
ALDH1A1 P00352 4/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
MAPT P10636 1/20 0.41
TSHR P16473 1/20 0.40
RECQL P46063 2/20 0.39
KDM4E B2RXH2 1/20 0.39
GLA P06280 1/20 0.39
HSD17B10 Q99714 1/20 0.39
EPHX1 P07099 1/20 0.39
GPR119 Q8TDV5 3/20 0.39
NR1H2 P55055 1/20 0.39
GAA P10253 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
LMNA P02545 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
JAK2 O60674 1/20 0.37
JAK1 P23458 1/20 0.37
USP2 O75604 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18299092 0.90 GAA (0.46) ALDH1A1MAPTTSHRGAASMN1; SMN2
SCHEMBL26977968 0.87 HPGD (0.42) HPGDALDH1A1MEN1KMT2AMAPT
SCHEMBL29099043 0.87 HPGD (0.42) HPGDALDH1A1MEN1KMT2AMAPT
SCHEMBL29099046 0.87 HPGD (0.42) HPGDALDH1A1MEN1KMT2AMAPT
SCHEMBL15227428 0.87 HPGD (0.42) HPGDALDH1A1MEN1KMT2AMAPT
SCHEMBL26978292 0.87 HPGD (0.42) HPGDALDH1A1MEN1KMT2AMAPT
SCHEMBL5151599 0.87 HPGD (0.42) HPGDALDH1A1MEN1KMT2AMAPT
SCHEMBL26978667 0.87 HPGD (0.42) HPGDALDH1A1MEN1KMT2AMAPT
SCHEMBL9473363 0.86 THRB (0.40) ALDH1A1MEN1KMT2AMAPTGAA
SCHEMBL9473367 0.86 THRB (0.40) ALDH1A1MEN1KMT2AMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10100030-B2 Carboxymethyl piperidine derivative KISSEI PHARMACEUTICAL CO., LTD. (JP) 2018-10-16 US disclosed
EP-3067349-B1 CARBOXYMETHYL PIPERIDINE DERIVATIVE KISSEI PHARMACEUTICAL (JP) 2018-02-28 EP disclosed
US-20160289206-A1 CARBOXYMETHYL PIPERIDINE DERIVATIVE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2016-10-06 US disclosed
EP-3067349-A1 CARBOXYMETHYL PIPERIDINE DERIVATIVE Kissei Pharmaceutical Co., Ltd. (JP) 2016-09-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10100030-B2 Carboxymethyl piperidine derivative TACR1, CYP3A5, CNR1 HPGD 612/4885ALDH1A1 165/4885MEN1 3434/4885
US-20160289206-A1 CARBOXYMETHYL PIPERIDINE DERIVATIVE TACR1, CYP3A5, CNR1 HPGD 612/4885ALDH1A1 165/4885MEN1 3434/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.